DLG4 and Alzheimer disease: These results are in agreement with other previous reports utilizing an STZ-induced mouse model of AD, as in Gratuze et al. 42 and Guo et al. 24, in which levels of synaptophysin or PSD-95 remain unchanged after the ICV (3 mg/kg) of STZ.